Pretreatment with IL-6 or IL-10 could provide a protection in endotoxemia by inhibiting tissue degradation as it has already been established in our prior studies that pretreatment with IL-6 lowers liver damage in experimental endotoxemia by modulating ROS production and cell infiltration [66]. This evidence concerns the gene IL6 and serum lipopolysaccharide activity.